Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 826-704-5 | CAS number: 1631962-93-0
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
In this in vitro assessment of the mutagenic potential of FRET 11-0539, histidine-dependent auxotrophic mutants ofSalmonella typhimurium, strains TA1535, TA1537, TA98 and TA100, and a tryptophan-dependent mutant ofEscherichia coli, strain WP2 uvrA (pKM101), were exposed to FRET 11-0539 diluted in dimethyl sulphoxide (DMSO). DMSO was also used as a vehicle control.
Three independent mutation tests were performed in the presence and absence of liver preparations (S9 mix) from rats treated with phenobarbital and 5,6-benzoflavone. The first test was a standard plate incorporation assay; the second included a pre-incubation stage. A third mutation test using strain TA100 in the absence of S9 mix only was also performed, this test also included a pre-incubation stage.
Concentrations of FRET 11-0539 up to 5000 µg/plate were tested. This is the standard limit concentration recommended in the regulatory guidelines that this assay follows. Other concentrations used were a series ofcahalf-log10dilutions of the highest concentration.
No signs of toxicity towards the tester strains were observed in the first mutation test following exposure to FRET 11-0539. Toxicity (observed as a reduction in revertant colony numbers) was seen in strains TA98, TA100, and TA1537 in the absence of S9 mix and in strain TA1535 in the presence of S9 mix following exposure to FRET 11-0539 at concentrations up to 5000 µg/plate in the second test. Toxicity (observed as a thinning of the background lawn of non-revertant colonies and a reduction in revertant colony numbers) was seen in strain TA100 in the absence of S9 mix in the third test.
No evidence of mutagenic activity was seen at any concentration of FRET 11-0539 in any mutation test.
The concurrent positive controls verified the sensitivity of the assay and the metabolising activity of the liver preparations. The mean revertant colony counts for the vehicle controls were within or close to the current historical control range for the laboratory.
It was concluded that FRET 11-0539 showed no evidence of mutagenic activity in this bacterial system under the test conditions employed.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
